Showing results (51-60 of 227) with videos related to
Sort By:
Pageof 23
Leukemia & Lymphoma|October 25, 2008
High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphomaRenata Zaucha, Ted Gooley, Leona Holmberg, et al.Journal of Clinical Apheresis|February 3, 2012
The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34(+) cellsAjay K Gopal, Mehdi Karami, JoAl Mayor, et al.Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
A phase II, single-arm, open-label, multicenter study to evaluate the efficacy and safety of P276-00, a cyclin-dependent kinase inhibitor, in patients with relapsed or refractory mantle cell lymphomaRyan D Cassaday, Andre Goy, Suresh Advani, et al.JCO Oncology Practice|May 6, 2020
Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle StrategyMary-Elizabeth M Percival, Ryan C Lynch, Anna B Halpern, et al.The New Phytologist|November 24, 2016
Plant domestication and the assembly of bacterial and fungal communities associated with strains of the common sunflower, Helianthus annuusJonathan W Leff, Ryan C Lynch, Nolan C Kane, et al.Clinical Lymphoma, Myeloma & Leukemia|February 24, 2019
Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular LymphomaGilles Salles, Ajay K Gopal, Monique C Minnema, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Surveillance imaging for lymphoma: pros and consRyan C Lynch, Andrew D Zelenetz, James O Armitage, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest doseJoseph G Rajendran, Ajay K Gopal, Darrel R Fisher, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2004
High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumesJoseph G Rajendran, Darrell R Fisher, Ajay K Gopal, et al.British Journal of Haematology|February 12, 2022
The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic lymphocytic leukaemiaChaitra Ujjani, Mazyar Shadman, Ryan C Lynch, et al.Pageof 23